tm logo
LENTICLAIR
Live/Pending
PUBLISHED FOR OPPOSITION

on 12 Nov 2024

Last Applicant/ Owned by

Serial Number

79377485 filed on 13th Jul 2023

Registration Number

N/A

Correspondent Address

Max Moskowitz

Max Moskowitz OSTROLENK FABER LLP

Binger Str. 173

New York, NY 10022

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

LENTICLAIR

Medical and scientific research in the fields of respiratory diseases and inflammatory diseases; medical and scientific research in the field of cell and gene therapies; providing medical and scientific research information in the field of respiratory diseases and inflammatory diseases; providing medical and scientific research information in the field of cell and gene therapies

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research in the fields of respiratory diseases and inflammatory diseases; medical and scientific research in the field of cell and gene therapies; providing medical and scientific research information in the field of respiratory diseases and inflammatory diseases; providing medical and scientific research information in the field of cell and gene therapies


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79377485

Mark Type

No Service Mark

Attorney Docket Number

No TE/3974-1018

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Nov 2024PUBLISHED FOR OPPOSITION
23rd Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
26th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
26th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
26th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
24th Apr 2024REFUSAL PROCESSED BY IB
29th Mar 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29th Mar 2024REFUSAL PROCESSED BY MPU